This inventor holds 6 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignee: Astrazeneca Ab. Active years: 2021-2025.
Location History:
- Gothenburg, SE (2023)
- Södertälje, SE (2021 - 2024)
Company Filing History:
Years Active: 2021-2025
Title: The Innovations of Anna Maria Langkilde
Introduction
Anna Maria Langkilde is a prominent inventor based in Södertälje, Sweden. With a remarkable portfolio of four patents, she has made significant contributions to the field of medical treatment, particularly in managing chronic kidney disease and heart failure.
Latest Patents
Among her latest innovations are methods for treating chronic kidney disease with dapagliflozin. This patent focuses on treating patients with chronic kidney disease (CKD), both with and without Type 2 diabetes, using an SGLT2 inhibitor, specifically dapagliflozin. Another important patent involves methods for treating heart failure with reduced ejection fraction (HFrEF). This method also utilizes dapagliflozin to benefit patients with heart failure, addressing vital healthcare outcomes such as hospitalization due to worsening heart condition or cardiovascular death. These methods not only aim to improve patient health status and quality of life but also reduce the risk of adverse cardiovascular events.
Career Highlights
Anna Maria Langkilde is associated with AstraZeneca AB, a leading global biopharmaceutical company that focuses on the development of innovative medicines. Her work at AstraZeneca showcases her dedication to advancing healthcare through effective treatment solutions.
Collaborations
Throughout her career, she has collaborated with various researchers and professionals in the field of medicine. These collaborations have been essential in driving forward her innovative approaches to treating chronic diseases, highlighting the importance of teamwork in medical advancements.
Conclusion
Anna Maria Langkilde's contributions to the fields of chronic kidney disease and heart failure treatment underscore her significant role as an inventor. With her inventive spirit and commitment to improving patient care, Langkilde continues to pave the way for future innovations in healthcare.